Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Tips from these results
- Equal Weight Drax Group (DRX) by Barclays
- Buy Eurocell (ECEL) by Canaccord Genuity
- Buy Homeserve (HSV) by Berenberg
- Buy Premier Oil (PMO) by Canaccord Genuity
- Hold Sage Group (SGE) by Kevin Godbold in The Motley Fool
- Sell Thomas Cook Group (TCG) by Citi
- Buy Thomas Cook Group (TCG) by Jefferies
- Equal Weight Hurricane Energy (HUR) by Barclays
- Hold Eckoh (ECK) by Berenberg
- Overweight Beazley (BEZ) by Morgan Stanley
- Underweight Metro Bank (MTRO) by JP Morgan
- Neutral Sophos Group (SOPH) by JP Morgan
- Equal Weight Lancashire Holdings Limited (LRE) by Morgan Stanley
- Hold Greggs (GRG) by Berenberg
- Buy RSA Insurance Group (RSA) by Jefferies
- Equal Weight Hiscox Limited (DI) (HSX) by Morgan Stanley
- Underperform Ferguson (FERG) by Credit Suisse
- Neutral British Land Company (BLND) by JP Morgan
- Overweight Land Securities Group (LAND) by JP Morgan
- Overweight Relx plc (REL) by JP Morgan
AstraZeneca (AZN)
Health Care Sector
-
Latest quote
5,875.00p (mid)
-
Current Change (%)
-0.15%
-
Price
Bid: 5,871.00p
Offer: 5,872.00p
-
Today
High: 5,906.00p
Low: 5,830.97p
-
This year
High: 6,525.00p
Low: 5,182.00p
-
Information
Volume: 737,927
Market Cap: £77021.25M
AstraZeneca Overview
A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.AstraZeneca RNS Feed
| Title | Release date |
|---|---|
| Pooled analyses of the roxadustat global Phase III | 07:00 - May 10, 2019 |
| Director/PDMR Shareholding | 14:00 - May 8, 2019 |
| Director Declaration | 11:00 - May 8, 2019 |
| Trastuzumab deruxtecan demonstrated clinically | 07:00 - May 8, 2019 |
| Qternmet XR approved in the US for type-2 diabetes | 07:00 - May 3, 2019 |
| Total Voting Rights | 15:00 - May 1, 2019 |
| Director/PDMR Shareholding | 12:00 - May 1, 2019 |
| Lynparza receives positive EU CHMP opinion for 1st | 07:00 - April 29, 2019 |
| Result of AGM | 17:45 - April 26, 2019 |
| AZN: Q1 2019 Results | 07:00 - April 26, 2019 |
| Lynparza approved in EU for the treatment of germl | 07:00 - April 10, 2019 |
| Holding(s) in Company | 13:30 - April 4, 2019 |
| Director/PDMR Shareholding | 10:00 - April 3, 2019 |
| Total Voting Rights | 15:00 - April 2, 2019 |
| Astrazeneca | 18:00 - April 1, 2019 |
NOTE: This is based on 232 open tips for this company
